Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 01 - 14 symbols : BLUE save search
Outlook on the CAR T-cell Therapy Global Market to 2031 - by Product Type, Indications, End-user and Region
Published: 2022-01-14 (Crawled : 14:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -5.96%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
BLUE | $1.02 7.03% 6.11% 8.2M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
cel therapy t-cell
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
KUKE | $2.88 2.49% 7.64% 360K
|
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
BSBR | $5.25 2.54% 0.38% 430K
|
Finance
JOE 4 | $54.88 1.22% 0.22% 210K
|
Finance
MUSA 4 | $417.23 1.06% 0.01% 170K
|
Retail Trade
JBI 4 | $15.14 1.34% 0.0% 2.9M
|
SBS | $15.49 -1.59% -0.84% 4.6M
|
Utilities
ML 4 | $69.13 -4.48% -1.64% 110K
|
SG 4 | $20.65 -0.91% -2.14% 1.4M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.